Your browser doesn't support javascript.
loading
Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CM.
Epstein, Mara M; Dutcher, Sarah K; Maro, Judith C; Saphirak, Cassandra; DeLuccia, Sandra; Ramanathan, Muthalagu; Dhawale, Tejaswini; Harchandani, Sonali; Delude, Christopher; Hou, Laura; Gertz, Autumn; DiNunzio, Nina; McMahill-Walraven, Cheryl N; Selvan, Mano S; Vigeant, Justin; Cole, David V; Leishear, Kira; Gurwitz, Jerry H; Andrade, Susan; Cocoros, Noelle M.
Afiliación
  • Epstein MM; Division of Geriatric Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Dutcher SK; The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MA, USA.
  • Maro JC; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Saphirak C; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • DeLuccia S; Division of Geriatric Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Ramanathan M; The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MA, USA.
  • Dhawale T; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Harchandani S; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts, USA.
  • Delude C; Division of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Hou L; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts, USA.
  • Gertz A; The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, Worcester, MA, USA.
  • DiNunzio N; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • McMahill-Walraven CN; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Selvan MS; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Vigeant J; Aetna, a CVS Health company, Hartford, Connecticut, USA.
  • Cole DV; Humana Healthcare Research, Inc. (HHR), Sugar Land, Texas, USA.
  • Leishear K; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Gurwitz JH; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Andrade S; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Cocoros NM; Division of Geriatric Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Pharmacoepidemiol Drug Saf ; 30(7): 910-917, 2021 07.
Article en En | MEDLINE | ID: mdl-33899311
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Clasificación Internacional de Enfermedades Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Clasificación Internacional de Enfermedades Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido